Adage Capital Partners Gp, L.L.C. Vaxxinity, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,000,000 shares of VAXX stock, worth $480,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 3,000,000
-0.0%
Holding current value
$480,000
Previous $2.55 Million
15.29%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VAXX
# of Institutions
58Shares Held
12.2MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.62MShares$419,6880.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$385,8680.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$140,5660.0% of portfolio
-
State Street Corp Boston, MA799KShares$127,8830.0% of portfolio
-
Northern Trust Corp Chicago, IL333KShares$53,3200.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $17.9M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...